Jacob Wester, MD
Otolaryngology/Facial Plastic Surgery · Los Angeles, CANPI 1447693973
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,571 of the $1,756 with a category attached, or 89.4%. 11 manufacturers reported payments, led by AbbVie at 29.1% of the total. Reporting peaked in 2022 at $669 and has fallen 59.8% since, to $269 in 2025.
Across 44 payments — averaging $39.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$511
- Aerin Medical Inc.$409
- Inspire Medical Systems, Inc.$266
- Acclarent, Inc$210
- Sanofi$143
- Stryker$100
- plus $118 from 5 others
What the payments were for
- Travel & lodging$18611%
- Food & beverage$1,57189%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $511 |
| Aerin Medical Inc. | 12 | $409 |
| Inspire Medical Systems, Inc. | 8 | $266 |
| Acclarent, Inc | 5 | $210 |
| Sanofi | 4 | $143 |
| Stryker | 3 | $100 |
| Medtronic | 2 | $48 |
| Integra Lifesciences Corporation | 1 | $23 |
| Smith+Nephew | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Pentax Of America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,756 in reported general payments places this provider in the 60th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 263 | $10,058 |
| Fluticasone Propionate | 178 | $2,679 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 16 | $1,921 |
| Azelastine Hcl | 42 | $1,735 |
| Famotidine | 178 | $1,629 |
| Omeprazole | 170 | $1,212 |
| Pantoprazole Sodium | 41 | $585 |
| Levocetirizine Dihydrochloride | 49 | $567 |
| Mometasone Furoate | 20 | $358 |
| Doxycycline Hyclate | 34 | $332 |
| Fluconazole | 17 | $253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $190 |
| Mupirocin | 30 | $172 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $170 |
| Cephalexin | 35 | $148 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Los Angeles
- Jahangir SharifiLos Angeles$12K
- Jacob SedghLos Angeles$1K
- Kimberly LeeLos Angeles$1K
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Henry NguyenRancho Cucamonga$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.